Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 2, 2018
[ Mon, Jul 02nd 2018
] - WOPRAI
[ Mon, Jul 02nd 2018
] - WOPRAI
[ Mon, Jul 02nd 2018
] - WOPRAI
[ Mon, Jul 02nd 2018
] - WOPRAI
Fri, June 29, 2018
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
Arlinda Lee Maintained (CARA) at Strong Buy with Increased Target to $22 on, Jun 29th, 2018
Arlinda Lee of Canaccord Genuity, Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $21 to $22 on, Jun 29th, 2018.
Arlinda has made no other calls on CARA in the last 4 months.
There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Arlinda's Rating of Hold.
This is the rating of the analyst that currently disagrees with Arlinda
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018
Similar Stocks and Investing Articles
[ Thu, Jun 21st 2018
] - WOPRAI
[ Tue, Jun 12th 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Wed, May 23rd 2018
] - WOPRAI
[ Thu, May 10th 2018
] - WOPRAI
[ Fri, Jan 26th 2018
] - WOPRAI
[ Fri, Oct 27th 2017
] - WOPRAI
[ Wed, Oct 25th 2017
] - WOPRAI
[ Mon, Oct 23rd 2017
] - WOPRAI